BAILEE COOK: Open Payments
NPI 1942954888 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,164 in 96 payments from 43 companies in 2025. Trend: 2023 $1,247 · 2024 $1,424 · 2025 $2,164
Food & beverage: $1,958Education: $206
| Company | Payments | Amount |
|---|---|---|
| Octapharma USA, Inc. | 1 | $240 |
| Novartis Pharmaceuticals Corporation | 9 | $156 |
| ABBVIE INC. | 7 | $155 |
| Eisai Inc. | 5 | $143 |
| AstraZeneca Pharmaceuticals LP | 7 | $138 |
| Daiichi Sankyo Inc. | 5 | $102 |
| PFIZER INC. | 6 | $97 |
| Janssen Biotech, Inc. | 6 | $95 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| SEAGEN INC. | 1 | $90 |
Products named: OCTAGAM IMMUNE GLOBULIN (HUMAN), Lenvima, SARCLISA, Enhertu, Venclexta, Onivyde, TAGRISSO, IBRANCE.
Industry payments across NE — which companies pay providers there.
